RT Journal Article
SR Electronic
T1 Comparison of Capillary Blood Self-Collection using the Tasso-SST Device with Venous Phlebotomy for anti-SARS-CoV-2 Antibody Measurement
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.13.23286935
DO 10.1101/2023.03.13.23286935
A1 King, Elise R.
A1 Garrett, Haley E.
A1 Abernathy, Haley
A1 Cassidy, Caitlin A.
A1 Cabell, Cameron R.
A1 Shook-Sa, Bonnie E.
A1 Juliano, Jonathan J.
A1 Boyce, Ross M.
A1 Aiello, Allison E.
A1 Ciccone, Emily J.
YR 2023
UL http://medrxiv.org/content/early/2023/03/20/2023.03.13.23286935.abstract
AB Measuring seroprevalence over time is a valuable epidemiological tool for improving our understanding of COVID-19 immunity. Due to the large number of collections required for population surveillance as well as concerns about potential infection risk to the collectors, self-collection approaches are being increasingly pursued. To advance this methodology, we collected paired venous and capillary blood samples by routine phlebotomy and Tasso-SST device respectively from 26 participants and measured total immunoglobulin (Ig) and IgG antibodies to the SARS-CoV-2 receptor binding domain (RBD) by enzyme-linked immunosorbent assay (ELISA) on both specimens. Qualitatively, no discrepancies were noted in binary results between Tasso and venipuncture-derived plasma. Furthermore, in vaccinated participants, correlation between Tasso and venous total Ig and IgG specific antibody quantitative levels was high (Total Ig: ρ = 0.72, 95% CI (0.39- 0.90); IgG: ρ = 0.85, 95% CI (0.54, 0.96)). Our results support the use of Tasso at-home collection devices for antibody testing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by funds from the following sources:2007 Gillings Gift at the UNC Gillings School of Global Public Health to Allison AielloNorth Carolina Policy Collaboratory at the University of North Carolina at Chapel Hill with funding from the North Carolina Coronavirus Relief Fund established and appropriated by the North Carolina General Assembly to Ross BoyceUNC School of Medicine to RMBA generous donation to the UNC School of Medicine by an anonymous donor to Ross BoyceNational Institute of Occupational Safety and Health through Grant Award Number [75D30121P10086 0000HCCK-2021] to Allison Aiello and Emily CicconeNational Science Foundation through Grant Award Number NSF 20-4353 to Allison AielloNational Institutes of Health through Grant Award Number R01 EB0225021 to Allison AielloNational Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through Grant Award Number UL1TR001111 supported the use of the REDCap database. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.In addition, EJC was supported by the National Heart, Lung, and Blood Institute through Grant Award Number [5T32HL007106] during the study period, RMB is currently supported by the National Institute of Allergy and Infectious Diseases through Grant Award Number [5K23AI141764], JJJ is currently supported by the National Institute of Allergy and Infectious Diseases through Grant Award Number [5K24AI134990], and BES is supported by the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded program [P30AI050410].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of the University of North Carolina gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors